California State Teachers Retirement System (CalSTRS)’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-791
Closed -$39K 3376
2022
Q1
$39K Sell
791
-219
-22% -$11.3K ﹤0.01% 3093
2021
Q4
$76K Hold
1,010
﹤0.01% 3074
2021
Q3
$80K Sell
1,010
-1,576
-61% -$158K ﹤0.01% 3044
2021
Q2
$359K Buy
2,586
+542
+27% +$103K ﹤0.01% 2826
2021
Q1
$428K Buy
2,044
+450
+28% +$90.2K ﹤0.01% 2592
2020
Q4
$265K Hold
1,594
﹤0.01% 2721
2020
Q3
$271K Hold
1,594
﹤0.01% 2574
2020
Q2
$265K Buy
1,594
+479
+43% +$74.7K ﹤0.01% 2574
2020
Q1
$129K Buy
1,115
+13
+1% +$1.83K ﹤0.01% 2728
2019
Q4
$163K Sell
1,102
-28
-2% -$4.25K ﹤0.01% 2850
2019
Q3
$154K Buy
1,130
+217
+24% +$30.5K ﹤0.01% 2867
2019
Q2
$119K Buy
913
+515
+129% +$59.8K ﹤0.01% 2962
2019
Q1
$38K Buy
+398
New +$52.3K ﹤0.01% 2974

Other funds holding HARP

California State Teachers Retirement System (CalSTRS)'s HARP Position: Q2 2022 in Review

California State Teachers Retirement System (CalSTRS) sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2022, closing a stake of 791 shares — an estimated $39K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in HARP in Q1 2019 and held it in 13 quarters. The position peaked at $428K in Q1 2021. 63 funds tracked by Wall St. Rank hold HARP as of Q2 2022.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 791 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $39K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Harpoon Therapeutics, Inc. Common Stock position peaked at $428K in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2022.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.